0001127602-22-021922.txt : 20220901 0001127602-22-021922.hdr.sgml : 20220901 20220901181934 ACCESSION NUMBER: 0001127602-22-021922 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220901 FILED AS OF DATE: 20220901 DATE AS OF CHANGE: 20220901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIERENGA WENDALL CENTRAL INDEX KEY: 0001235945 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50633 FILM NUMBER: 221222665 MAIL ADDRESS: STREET 1: 12790 EL CAMINO REAL STREET 2: C/O NEUROCRINE BIOSCIENCES CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER NAME: FORMER CONFORMED NAME: WIERENGA WENDALL D DATE OF NAME CHANGE: 20030527 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTOKINETICS INC CENTRAL INDEX KEY: 0001061983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943291317 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 OYSTER POINT BOULEVARD STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 624-3000 MAIL ADDRESS: STREET 1: 350 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-09-01 0001061983 CYTOKINETICS INC CYTK 0001235945 WIERENGA WENDALL 350 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 1 Common Stock 2022-09-01 4 M 0 4166 6.78 A 16336 D Common Stock 2022-09-01 4 S 0 4166 52.79 D 12170 D Non-Qualified Stock Option (Right to Buy) 6.78 2022-09-01 4 M 0 4166 0 D 2013-06-22 2023-05-22 Common Stock 4166 0 D Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on July 1, 2022. /s/ John Faurescu, attorney-in-fact for Dr. Wierenga 2022-09-01